bladder transitional cell carcinoma
基本解釋
- [醫(yī)藥科學(xué)]膀胱癌膀胱腫瘤膀胱移行上皮細(xì)胞癌
英漢例句
- Objective To study the difference in gene expression between human bladder transitional cell carcinoma (TCC) and normal tissue.
目的研究膀胱移行上皮細(xì)胞癌(TCC)和正常組織差異表達(dá)基因。 - Objective:To evaluate the clinical value of detecting urine soluble cytokeratin19fragment (CYFRA21-1)in diagnosing bladder transitional cell carcinoma.
目的:探討尿可溶性細(xì)胞角蛋白19片段(CYFRA21-1)診斷膀胱移行細(xì)胞癌價(jià)值。 - Objective To investigate the correlation of clinical and pathological characteristics of bladder transitional cell carcinoma(BTCC) with platelet-derived endothelial cell growth factor (PD-ECGF).
目的探討血小板源性內(nèi)皮細(xì)胞生長(zhǎng)因子(PD ECGF)與膀胱移行細(xì)胞癌(BTCC)的相關(guān)性。
雙語(yǔ)例句
詞組短語(yǔ)
- bladder plasmacytoid transitional cell carcinoma 膀胱漿細(xì)胞樣移行細(xì)胞癌
- Bladder neoplasm Transitional cell carcinoma 膀胱移行細(xì)胞癌
- Bladder transitional cell carcinoma BTCC 膀胱移行細(xì)胞癌
- human bladder transitional cell carcinoma 膀胱移行細(xì)胞癌
- superficial bladder transitional cell carcinoma 淺表性膀胱移行細(xì)胞癌
短語(yǔ)
專業(yè)釋義
- 膀胱癌
Conclusion COX-2,MMP-2 and VEGF play an important role in the invasion step of bladder transitional cell carcinoma. The detection of their expressions may become a new approach to the diagnosis of urothelial carcinomas.
結(jié)論COX-2、MMP-2和VEGF參與膀胱癌侵襲轉(zhuǎn)移,在膀胱移行細(xì)胞癌中的表達(dá)對(duì)其診斷及預(yù)后判斷具有參考價(jià)值。 - 膀胱腫瘤
20 cases of bladder transitional cell carcinoma samples were accessed in the process of open surgery and 26 cases of samples were accessed in the process of Pathological examination.
20例腫瘤標(biāo)本為在開放手術(shù)過程中獲取,26例腫瘤標(biāo)本為等離子膀胱腫瘤電切除術(shù)前活組織檢查時(shí)獲取。 - 膀胱移行上皮細(xì)胞癌